763 results on '"Yang, Chang-Hao"'
Search Results
2. Relationship between genotype, phenotype, and refractive status in patients of inherited retinal degeneration
3. High prevalence of exon-13 variants in USH2A-related retinal dystrophies in Taiwanese population
4. Metabolomics facilitates differential diagnosis in common inherited retinal degenerations by exploring their profiles of serum metabolites
5. Efficacy and safety of intravitreal faricimab for neovascular age-related macular degeneration: a systematic review and meta-analysis
6. Two-Year Real-World Results for Aflibercept Using the Treat-and-Extend Regimen in Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy
7. Literature- and Experience-Based Consensus for Acute Post-operative Endophthalmitis and Endogenous Endophthalmitis in Taiwan
8. Intravitreal Aflibercept for the Treatment of Diabetic Macular Edema in Routine Clinical Practice: Results from the 24-Month AURIGA Observational Study
9. Real-World Management of Macular Edema Secondary to Retinal Vein Occlusion with Intravitreal Aflibercept: 24-month Results from the AURIGA Observational Study
10. Long-Term Change in Renal Function After Intravitreal Anti-VEGF Treatment for Diabetic Macular Edema: A 2-Year Retrospective Cohort Study
11. Refining vitrectomy for proliferative diabetic retinopathy
12. SURGICAL OUTCOMES AND INTRAOPERATIVE PARAMETERS OF THREE-DIMENSIONAL VISUALIZATION SYSTEM VERSUS CONVENTIONAL MICROSCOPES FOR MACULAR SURGERY IN HIGHLY MYOPIC EYES: A Prospective Randomized Clinical Trial
13. Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials
14. Association between non-steroidal anti-inflammatory drug use and development of age-related macular degeneration—A 10-year retrospective cohort study
15. Vitreoretinal Interface Changes After Anti-vascular Endothelial Growth Factor Treatment in Highly Myopic Eyes: A Real-World Study
16. The development and evolution of lamellar macular hole in highly myopic eyes
17. Cytomegalovirus Uveitis: Taiwan expert consensus
18. Quantitative analysis of branching neovascular networks in polypoidal choroidal vasculopathy by optical coherence tomography angiography after photodynamic therapy and anti-vascular endothelial growth factor combination therapy
19. Step-wise diagnostic approach for patients with uveitis - Experts consensus in Taiwan
20. The Role of Fractalkine in Diabetic Retinopathy: Pathophysiology and Clinical Implications.
21. Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials
22. Baseline predictors for good visual gains after anti-vascular endothelial growth factor therapy for myopic choroidal neovascularization
23. Optimal approaches and criteria to treat-and-extend regimen implementation for Neovascular age-related macular degeneration: experts consensus in Taiwan
24. Management of neovascular age-related macular degeneration: Taiwan expert consensus
25. Treat-and-Extend Regimens for the Management of Neovascular Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy: Consensus and Recommendations From the Asia-Pacific Vitreo-retina Society
26. Application of deep learning image assessment software VeriSee™ for diabetic retinopathy screening
27. Artificial Intelligence–Assisted Early Detection of Retinitis Pigmentosa — the Most Common Inherited Retinal Degeneration
28. Impact of Anti—Vascular Endothelial Growth Factor Treatment on Neovascular Age-Related Macular Degeneration with and without Retinal Pigment Epithelial Detachment: A Real-World Study.
29. Fluid Biomarkers in Optical Coherence Tomography for Visual Outcome in Polypoidal Choroidal Vasculopathy
30. Choroidal Changes in Patients with Diabetic Retinopathy: A Retrospective Study
31. One-year outcomes of the treat-and-extend regimen using aflibercept for the treatment of diabetic macular edema
32. Management of polypoidal choroidal vasculopathy: Experts consensus in Taiwan
33. Management of diabetic macular edema: experts’ consensus in Taiwan
34. Correlations between visual acuity and macular microvasculature quantified with optical coherence tomography angiography in diabetic macular oedema
35. Real world experience of the treatment outcome between photodynamic therapy combined with ranibizumab and aflibercept monotherapy in polypoidal choroidal vasculopathy
36. Hyperreflective foci in predicting the treatment outcomes of diabetic macular oedema after anti-vascular endothelial growth factor therapy
37. Flap technique-assisted surgeries for advanced retinitis pigmentosa complicated with macular hole: a case report and literature review
38. Comparison of visual outcomes between therapy choices and subtypes of polypoidal choroidal vasculopathy (PCV) in Taiwan: a real-world study
39. Clinical features and prognosis of polypoidal choroidal vasculopathy with different morphologies of branching vascular network on optical coherence tomography angiography
40. Combined quantitative and qualitative optical coherence tomography angiography biomarkers for predicting active neovascular age-related macular degeneration
41. The structure–function correlation analysed by OCT and full field ERG in typical and pericentral subtypes of retinitis pigmentosa
42. Genetic characteristics and epidemiology of inherited retinal degeneration in Taiwan
43. Full-thickness macular hole formation in proliferative diabetic retinopathy
44. OCT Angiography Biomarkers for Predicting Visual Outcomes after Ranibizumab Treatment for Diabetic Macular Edema
45. Prognostic factors for combined ranibizumab and prompt verteporfin photodynamic therapy for polypoidal choroidal vasculopathy
46. One-year outcomes of the treat-and-extend regimen using aflibercept for the treatment of diabetic macular edema
47. HYPERREFLECTIVE FOCI AS IMPORTANT PROGNOSTIC INDICATORS OF PROGRESSION OF RETINITIS PIGMENTOSA
48. Genetics in neovascular age‐related macular degeneration susceptibility and treatment response to anti‐VEGF intravitreal injection: A case series study.
49. Treatment outcomes and predicting factors for diabetic macular edema treated with ranibizumab – One-year real-life results in Taiwan
50. Faricimab Treat-and-Extend for Diabetic Macular Edema
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.